Microsaic Systems - Trading Update
30/06/2022 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220630:nRSd7308Qa&default-theme=true
RNS Number : 7308Q Microsaic Systems plc 30 June 2022
30 June 2022
Microsaic Systems plc
("Microsaic" or the "Company")
Trading Update
H1 2022 revenues up 40% due to new services division
Strong H2 2022 order book for services continues to grow
Microsaic Systems plc (AIM: MSYS), is pleased to announce an unaudited trading
update for the six months ended 30 June 2022 ("H1 2022"). The launch of the
Microsaic Services Division, earlier this year, has resulted in an uplift of
40% in revenues to £701k in H1 2022 (H1 2021: £499k) and a healthy order
book for H2. The provision of these services only commenced in April and
include R&D Engineering Consultancy, Analytical and AI Software Service
Programmes designed for the medical device, environmental, aerospace and food
industries.
The Company's website has also been updated to highlight the additional
services being offered by the Microsaic team.
Gerry Brandon, Acting Executive Chairman of Microsaic Systems plc, commented
"Microsaic's new high-tech services division has quickly generated revenues
and has helped transition the Company from product sales to customer-centric
service solutions in Human and Environmental Health so far. We are exploring
opportunities and already identified multiple sources of revenues including
strategic partners and OEM agreements, we have a healthy order book for H2
2022 which is the strongest ever going in to the second half."
Enquiries:
Microsaic Systems plc +44 (0) 734 0055 648
Gerry Brandon, Executive Chairman
N+1 Singer (Nominated Adviser & Joint Broker) +44 (0)20 7496 3000
Aubrey Powell / George Tzimas (Corporate Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Limited (Joint Broker) +44 (0) 20 3657 0050
Andy Thacker / James Pope
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information as stipulated under
the UK version of the market abuse regulation no 596/2014 which is part of
English law by virtue of the European (withdrawal) act 2018, as amended. On
publication of this announcement via a regulatory information service, this
information is considered to be in the public domain.
About Microsaic Systems
Microsaic floated on AIM in 2011 to develop and commercialise
micro-engineering chip-based mass spectrometry equipment. Having invested
c. £30m over 20 years of development, Microsaic has a robust and
innovative patent portfolio in cutting-edge technology designed and developed
for "Industry 4.0" application. Microsaic serves markets in Human
Health, Environmental Health and Diversified Industries. Microsaic's system
solutions enable analytical detection and characterisation at the
point-of-need, whether within a conventional laboratory setting, or within a
bioprocessing facility for continuous MS detection data at multiple steps in
the process workflow.
Microsaic's products and systems are commercially available through global
markets via a network of regional and local partners, targeting its core
laboratory, manufacturing and point of need applications.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END TSTBKCBDBBKBOAB